Updated:
VirTrial
VirTrial is a Scottsdale-based clinical trial software firm serving small and mid-size research sites with a platform for decentralized and hybrid studies.
VirTrial
VirTrial was founded in 2010 in Scottsdale, Arizona, by an executive team that included former healthcare IT and trial management professionals. The firm's core product is a site-facing platform designed to streamline patient recruitment, scheduling, data capture, and regulatory workflows for clinical research centers. The company targets an asset class of clinical trial technology, competing with larger eClinical providers by focusing on the needs of independent and community-based research sites. Its platform supports decentralized and hybrid trial models, enabling remote consent, telehealth visits, and direct-to-patient data collection. Clients include research sites across North America, with some international reach. No senior executives or investment professionals are publicly listed on the firm's website as of early 2026. The company has not disclosed team size or total deployment raised. VirTrial has not publicly stated whether it has raised venture capital or operates as a bootstrapped entity. A structural differentiator for VirTrial is its focus on serving the underserved segment of small to mid-size research sites, which historically lacked affordable, easy-to-use eClinical tools. This positions the firm as an operational alternative to expensive enterprise platforms, with a mandate to improve trial diversity and access.
General information
Firm type
RIA
Year founded
2010
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Scottsdale
Corporate office
Scottsdale, AZ, United States
Sector focus
Frequently asked questions
Who runs investment decisions at VirTrial?
VirTrial's executive team is not publicly disclosed on its website or in standard business registries. The firm's leadership structure remains opaque, with no named CEO, CIO, or managing partners listed publicly as of early 2026.
How does VirTrial source proprietary deal flow?
VirTrial does not appear to operate as an investment firm with proprietary deal flow. It is a technology company that develops and sells clinical trial software to research sites, sponsors, and CROs. No investment activity or fund structures have been identified.
Is VirTrial structured as a single family office or does it operate more like a venture firm?
Public records indicate VirTrial is a private company, not a family office or venture capital firm. Its primary business operation is software development for clinical trials. No family office or investment vehicle structures have been associated with the entity.
Does VirTrial participate in fund commitments or only direct deals?
No evidence suggests VirTrial engages in fund commitments, direct investments, or any capital allocation activity. The firm operates exclusively as a clinical trial technology vendor.
What investment stages does VirTrial typically target?
VirTrial does not invest capital externally. The company's platform is deployed at clinical research sites at the study level, typically supporting Phase II-IV trials. The firm does not participate in venture-stage backing or any investment lifecycle.
Which sectors does VirTrial explicitly avoid?
VirTrial does not publish an investment mandate or sector-exclusion list. As a software provider, its focus is limited to clinical trial operations within healthcare and life sciences.
Where does the underlying wealth come from?
No wealth origin is disclosed for VirTrial. The firm is not a family office or asset manager, and its ownership structure does not appear to derive from a specific fortune or family.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: